澳大利亚卫生监管机构加强了对药用大麻处方的监督,以确保患者的安全。 Australia's health regulator tightens oversight on medicinal cannabis prescriptions to ensure patient safety.

澳大利亚的卫生监管机构Ahpra正在加紧努力,确保在对病人需求和不当处方的关切下,安全地开药用大麻。 Australia's health regulator, Ahpra, is stepping up efforts to ensure safe prescribing of medicinal cannabis, amid concerns over patient demand and inappropriate prescriptions. Ahpra正在警告保健专业人员优先注意病人的安全,并对开处方率高的从业者进行调查。 Ahpra is warning health professionals to prioritize patient safety and is investigating practitioners with high prescribing rates. 该机构虽然没有加强现有规则,但建议更严格地制定准则并进行监测,特别是在社交媒体上针对年轻人的营销做法方面。 While not tightening existing rules, the agency recommends stricter guidelines and monitoring, especially regarding marketing practices targeting young people on social media.